Weight loss drugs linked to loss of hair in major new study

Weight loss drugs have been linked to hair loss, a new study has claimed.People on GLP-1 agonist drugs, such as Mounjaro, Ozempic and Wegovy, have been reporting hair loss to regulators and a new study on around 50,000 people appears to support the link.GLP-1s are primarily used to treat diabetes and obesity by mimicking hormones to regulate blood sugar and reduce appetite.Experts used data to compare rates of alopecia hair loss in adults using GLP-1s to manage diabetes with those on other drugs.The team from the University of Pennsylvania Health System noted that regulators in the US have been informed of the link between the drugs and hair loss, particularly for semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro).So far in 2026, the UK Medicines and Healthcare products Regulatory